Private equity leaders offer a unique perspective on where healthcare is heading and which innovations are gaining momentum. In this session, Amy Christensen, Senior Partner and Co-Head of Healthcare of The Vistria Group; Jo Natauri, Founder and Managing Partner of Invidia Capital Management; Lee Shapiro, Managing Partner of 7wire Ventures; and Marisa Greenwald, Partner, Health […]
You are unauthorized to view this page. Username Password Remember Me Forgot Password
By January 2026, 82% of all practicing U.S. physicians were employed by hospitals or corporate entities, up from 52% at the start of 2018, according to an Avalere study sponsored by Physicians Advocacy Institute. Corporate entities, including insurers and private equity, grew their physician workforce from roughly 77,800 to roughly 149,600, a 92.3% increase since
Only 1 in 5 Physicians Is Independent Read More »
You are unauthorized to view this page.
Only 1 in 5 Physicians Is Independent Read More »
Oncology commands roughly 40% of the national drug spend. Retina is close behind. “If you follow the drug spend, you’ll find that the distributors are really building an ecosystem around it,” says Jeanne Proia, managing director at Cross Keys Capital and president of its healthcare services group. In this conversation with McGuireWoods partner and host
Oncology and Retina: Follow the Drug Spend, with Jeanne Proia Read More »
You are unauthorized to view this page.
Oncology and Retina: Follow the Drug Spend, with Jeanne Proia Read More »
Independent physician practices increasingly view technology as the lever that will keep them independent, even as acquisition offers and operational pressure intensify, according to a survey by Veradigm. Sixty-nine percent of respondents said they are extremely or very confident their practice will remain independent over the next three to five years, but only 6% reported
4 in 5 Independent Practices Say This Is What’s Keeping Them Independent Read More »
You are unauthorized to view this page.
4 in 5 Independent Practices Say This Is What’s Keeping Them Independent Read More »
Few sectors are more consistently in the crosshairs of congressional oversight than healthcare. In the 119th Congress, Republican committee chairs have pursued investigations into group purchasing organizations (GPOs), pharmacy benefit managers (PBMs), Affordable Care Act (ACA) plans, healthcare fraud, insurance costs, data breaches, drug pricing and hospital systems using hearings, detailed information requests and subpoenas.
Warning Signs: Potential Congressional Investigations in Healthcare Read More »
You are unauthorized to view this page.
Warning Signs: Potential Congressional Investigations in Healthcare Read More »
